Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT02786927 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

214

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Placebo ELLIPTA device
DRUG: Placebo capsules for use in HANDIHALER device
OTHER: Inhaler Preference Questionnaire Version 1
OTHER: Inhaler Preference Questionnaire Version 2

Sponsor

GlaxoSmithKline